Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


09.07.2018

1 Ann Thorac Surg
3 Anticancer Res
2 BMC Cancer
1 Cancer Sci
1 Clin Cancer Res
1 J Thorac Oncol
1 Lung Cancer
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. CAO J, Hu J
    Recording Margin Distance is Crucial in Limited Pulmonary Resection for Lung Cancer (Reply).
    Ann Thorac Surg. 2018 Jun 30. pii: S0003-4975(18)30898.
    PubMed     Text format    


    Anticancer Res

  2. BAXA J, Matouskova T, Ludvik J, Sedlmair M, et al
    Single-source Dual-energy CT as a Part of (18)F-FDG PET/CT: Direct Comparison of Iodine-related and Metabolic Parameters in Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:4131-4137.
    PubMed     Text format     Abstract available

  3. SCHMID S, Csanadi A, Kozhuharov N, Tchudjin M, et al
    CC-Chemokine Ligand 18 Is an Independent Prognostic Marker in Lymph Node-positive Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:3913-3918.
    PubMed     Text format     Abstract available

  4. MAIUTHED A, Chantarawong W, Chanvorachote P
    Lung Cancer Stem Cells and Cancer Stem Cell-targeting Natural Compounds.
    Anticancer Res. 2018;38:3797-3809.
    PubMed     Text format     Abstract available


    BMC Cancer

  5. HIGUCHI Y, Motoki T, Ishida H, Kanamitsu K, et al
    Sorafenib treatment for papillary thyroid carcinoma with diffuse lung metastases in a child with autism spectrum disorder: a case report.
    BMC Cancer. 2017;17:775.
    PubMed     Text format     Abstract available

  6. SHENG Y, Xu M, Li C, Xiong Y, et al
    Nm23-H1 is involved in the repair of ionizing radiation-induced DNA double-strand breaks in the A549 lung cancer cell line.
    BMC Cancer. 2018;18:710.
    PubMed     Text format     Abstract available


    Cancer Sci

  7. MURAKAMI H, Nokihara H, Hayashi H, Seto T, et al
    Clinical activity of ASP8273 in Asian patients with non-small cell lung cancer with EGFR activating and T790M mutations.
    Cancer Sci. 2018 Jul 4. doi: 10.1111/cas.13724.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  8. ROMANIELLO D, Mazzeo L, Mancini M, Marrocco I, et al
    A Combination Of Approved Antibodies Overcomes Resistance Of Lung Cancer To Osimertinib By Blocking Bypass Pathways.
    Clin Cancer Res. 2018 Jul 2. pii: 1078-0432.CCR-18-0450.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  9. WU YL, Lu S, Lu Y, Zhou J, et al
    Results of PROFILE 1029, a Phase III Comparison of First-Line Crizotinib versus Chemotherapy in East Asian Patients with ALK-Positive Advanced Non-Small Cell Lung Cancer.
    J Thorac Oncol. 2018 Jun 29. pii: S1556-0864(18)30721.
    PubMed     Text format     Abstract available


    Lung Cancer

  10. ANDREAS S, Chouaid C, Danson S, Siakpere O, et al
    Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Lung Cancer. 2018 Jun 9. pii: S0169-5002(18)30416.
    PubMed     Text format     Abstract available


    PLoS One

  11. ROTH JA, Carter-Harris L, Brandzel S, Buist DSM, et al
    A qualitative study exploring patient motivations for screening for lung cancer.
    PLoS One. 2018;13:e0196758.
    PubMed     Text format     Abstract available

  12. HEIDEN BT, Chen G, Hermann M, Brown RKJ, et al
    18F-FDG PET intensity correlates with a hypoxic gene signature and other oncogenic abnormalities in operable non-small cell lung cancer.
    PLoS One. 2018;13:e0199970.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: